LYONS GARY A Insider Trades

Insider Trading History

Track insider trading activity for LYONS GARY A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.67M 62,400 shares
Last Trade
Aug 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$317k 5,000 shares
$63.38
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.92M 66,500 shares
Last Trade
Aug 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$320k 5,000 shares
$63.90
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $0 0 shares
Last Trade
Aug 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$320k 5,000 shares
$63.90
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $294k 5,000 shares
Last Trade
Aug 17, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 5,000 shares
$63.53
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.8M 64,600 shares
Last Trade
Aug 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$316k 5,000 shares
$63.20
$58.88
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $372k 2,624 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$609k 3,908 shares
$155.83
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $17.3M 122,141 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$258k 1,659 shares
$155.50
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$258k 1,659 shares
$155.50
$141.84
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.62M 61,500 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 4,000 shares
$42.26
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $707k 12,000 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$507k 12,000 shares
$42.26
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.86M 65,500 shares
Last Trade
Apr 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$337k 8,000 shares
$42.13
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $0 0 shares
Last Trade
Apr 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$337k 8,000 shares
$42.13
$58.88
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.39M 57,500 shares
Last Trade
Apr 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$329k 8,000 shares
$41.07
$58.88
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
Dec 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.28M 15,000 shares
$151.96
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $17.1M 120,482 shares
Last Trade
Dec 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.29M 15,000 shares
$152.61
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $19.2M 135,482 shares
Last Trade
Dec 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.28M 15,000 shares
$151.96
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $17.1M 120,482 shares
Last Trade
May 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 1,435 shares
$119.12
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 1,435 shares
$119.12
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $469k 3,305 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$398k 3,305 shares
$120.56
$141.84
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.39M 57,500 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$412k 19,500 shares
$21.15
$58.88

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up